DERM vs EXPE · rev $34.5M vs P/E 20, rev $7.74B
Journey Medical Corp (DERM) versus Expedia Group Inc. (EXPE) — a side-by-side from cached financials, not a winner call.
Journey Medical Corp (DERM) is a drug manufacturers - specialty & generic company listed on US.
Expedia Group Inc. (EXPE) is a travel services company listed on US.
Latest reported DERM revenue for 2026-06-30 was $34.5M. Net income was -$2.5M. DERM currently screens at market cap $163.1M.
Latest reported EXPE revenue for 2026-06-30 was $7.74B. Net income was $872.0M. EXPE currently screens at market cap $21.71B and trailing P/E 20.4.
DERM currently screens at market cap $163.1M. EXPE currently screens at market cap $21.71B and trailing P/E 20.4.
Not investment advice. Open the DERM and EXPE stock pages for the full models.
Not investment advice.